Skip to main content
. Author manuscript; available in PMC: 2019 Feb 11.
Published in final edited form as: J Drug Metab Toxicol. 2015 Aug 13;6(4):187. doi: 10.4172/2157-7609.1000187

Figure 3: UPS dysregulation in neurodegenerative disorders.

Figure 3:

Almost all neurodisorders of contemporary interest are characterized by imbalanced UPS function, indicating the possible role of modulators of UPS as adjunct therapy.